Disease on EC 1.8.3.4 - methanethiol oxidase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Acute Coronary Syndrome
Circulating levels of selenium-binding protein 1 (SELENBP1) are associated with risk for major adverse cardiac events and death.
Acute Kidney Injury
Identification of a sensitive urinary biomarker, selenium-binding protein 1, for early detection of acute kidney injury.
Adenocarcinoma
Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Adenocarcinoma of Lung
Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Adenocarcinoma of Lung
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Adenoma
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Barrett Esophagus
Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity.
Bradycardia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Brain Ischemia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Breast Neoplasms
Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
Carcinogenesis
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Carcinogenesis
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Carcinogenesis
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Carcinoma
Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.
Carcinoma
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Carcinoma
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Carcinoma
Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
Carcinoma
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Carcinoma
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Carcinoma
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Carcinoma
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Carcinoma
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Carcinoma, Hepatocellular
Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1? to promote hepatocellular carcinoma invasiveness.
Carcinoma, Hepatocellular
Evaluation of selenite effects on selenoproteins and cytokinome in human hepatoma cell lines.
Carcinoma, Hepatocellular
Hepatitis B Virus-X Downregulates Expression of Selenium Binding Protein 1.
Carcinoma, Hepatocellular
Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4.
Carcinoma, Renal Cell
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Carcinoma, Squamous Cell
Downregulation of selenium-binding protein 1 is associated with poor prognosis in lung squamous cell carcinoma.
Carcinoma, Squamous Cell
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Cholangiocarcinoma
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
Colitis
DNA Methylation of miR-122 Aggravates Oxidative Stress in Colitis Targeting SELENBP1 Partially by p65NF-?B Signaling.
Colonic Neoplasms
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Colorectal Neoplasms
Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer.
Colorectal Neoplasms
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Colorectal Neoplasms
Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Colorectal Neoplasms
Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.
Congenital Abnormalities
Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish.
Cysts
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Fatty Liver
Identification of a differentially-expressed gene in fatty liver of overfeeding geese.
Glaucoma
Integrated microarray analysis provided novel insights to the pathogenesis of glaucoma.
Head and Neck Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Heart Arrest
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Hypopharyngeal Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Infertility
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Laryngeal Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Liver Cirrhosis
Quantitative chemical proteomics for investigating the biomarkers of dioscin against liver fibrosis caused by CCl4 in rats.
Lung Injury
[Relationship between the expression of heat shock protein 25 and selenium binding protein 1 with ischemia/reperfusion lung injury in vivo: experiment with rats]
Lung Neoplasms
Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma.
Lung Neoplasms
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Lymphatic Metastasis
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Lymphatic Metastasis
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Mouth Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Myocardial Infarction
Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.
Myocardial Infarction
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Myocardial Ischemia
Selenium-Binding Protein 1 Indicates Myocardial Stress and Risk for Adverse Outcome in Cardiac Surgery.
Nasopharyngeal Carcinoma
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Neoplasm Metastasis
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Neoplasm Metastasis
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Neoplasm Metastasis
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Neoplasms
Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions.
Neoplasms
Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
Neoplasms
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Neoplasms
Evaluation of autoantibody signatures in meningioma patients using human proteome arrays.
Neoplasms
Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
Neoplasms
Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and gleason score in human prostate tissue.
Neoplasms
Molecular cross-talk between members of distinct families of selenium containing proteins.
Neoplasms
Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis.
Neoplasms
Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Neoplasms
Quantitative Proteomics Analysis Integrated with Microarray Data Reveals That Extracellular Matrix Proteins, Catenins, and P53 Binding Protein 1 Are Important for Chemotherapy Response in Ovarian Cancers.
Neoplasms
Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition.
Neoplasms
Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Neoplasms
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma.
Neoplasms
Reduction of selenium-binding protein 1 sensitizes cancer cells to selenite via elevating extracellular glutathione: A novel mechanism of cancer-specific cytotoxicity of selenite.
Neoplasms
Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome.
Neoplasms
Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Neoplasms
Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification.
Neoplasms
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Neoplasms
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Neoplasms
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Neoplasms
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Neoplasms
Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts.
Neoplasms
Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Neoplasms, Squamous Cell
The Function and Significance of SELENBP1 Downregulation in Human Bronchial Epithelial Carcinogenic Process.
Neoplastic Processes
Inherited cancer predisposition sensitizes colonic mucosa to address Western diet effects and putative cancer-predisposing changes on mouse proteome.
Non-alcoholic Fatty Liver Disease
Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.
Ovarian Neoplasms
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Ovarian Neoplasms
Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.
Polycystic Ovary Syndrome
A nontargeted proteomic study of the influence of androgen excess on human visceral and subcutaneous adipose tissue proteomes.
Primary Ovarian Insufficiency
Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer.
Prostatic Neoplasms
Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer.
Prostatic Neoplasms
Selenium-binding protein 1 alters energy metabolism in prostate cancer cells.
Prostatic Neoplasms
Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Spinal Cord Injuries
Selenium-Binding Protein 1 (SELENBP1) as Biomarker for Adverse Clinical Outcome After Traumatic Spinal Cord Injury.
Spinal Curvatures
Protective Effects of Sal B on Oxidative Stress-Induced Aging by Regulating the Keap1/Nrf2 Signaling Pathway in Zebrafish.
Squamous Cell Carcinoma of Head and Neck
Downregulation of SELENBP1 enhances oral squamous cell carcinoma chemoresistance through KEAP1-NRF2 signaling.
Squamous Cell Carcinoma of Head and Neck
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Stomach Neoplasms
Suppression of selenium-binding protein 1 in gastric cancer is associated with poor survival.
Tonsillar Neoplasms
Selenium-binding protein 1 in head and neck cancer is low-expression and associates with the prognosis of nasopharyngeal carcinoma.
Urinary Bladder Neoplasms
Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
Wasting Syndrome
Selenium-binding protein 1: Its physiological function, dependence on aryl hydrocarbon receptors, and role in wasting syndrome by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
html completed